+39 02 610346.1 - info@newron.com

Investors and Media

Investors and Media

Newron Pharmaceuticals is headquartered in Bresso, Italy and its shares are listed on SIX Swiss Exchange under the ticker symbol NWRN. Newron is committed to providing reliable and transparent information about our business in an open and timely manner. This area contains investment and shareholder information, including our latest share price, key financial data and presentations and webcasts.


Newron news see all

Shareholders accepted all motions at the AGM 2018


Newron announces 2017 financial results and provides outlook for 2018


Newron Supports Global Rare Disease Day® 2018 and Rett Syndrome Studies


Change in the Board of Directors


Primary endpoint met in phase II/III clinical study of investigational Parkinson’s disease treatment safinamide in Japan

Stock information

Download centre

Email alerts






Upcoming Eventssee all

Family Office Capital Day am 24. April 2018

April 24, 2018 - Hotel Imperial, Austria

11th Kempen Life Sciences Conference

April 18-19, 2018 - Amsterdam, The Netherlands

Leerink Partners CNS Day

April 18, 2018 - Convene Conference Center, New York, USA